Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 Infection in Pregnancy: A Review.
Mily SJ, Akter KM, Jabin N, Mitra S, Emran TB, Nandi M, Baral SK, Uddin MZ, Mallick J, Paul A, Shah SUA, Rauf A, Khan IN, Mubarak MS. Mily SJ, et al. Among authors: emran tb. Infect Disord Drug Targets. 2022;22(5):e050122199976. doi: 10.2174/1871526522666220105111358. Infect Disord Drug Targets. 2022. PMID: 34986776 Review.
Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review.
Chopra H, Bibi S, Goyal R, Gautam RK, Trivedi R, Upadhyay TK, Mujahid MH, Shah MA, Haris M, Khot KB, Gopan G, Singh I, Kim JK, Jose J, Abdel-Daim MM, Alhumaydhi FA, Emran TB, Kim B. Chopra H, et al. Among authors: emran tb. Front Oncol. 2022 Jul 12;12:925379. doi: 10.3389/fonc.2022.925379. eCollection 2022. Front Oncol. 2022. PMID: 35903701 Free PMC article. Review.
Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.
Mumu M, Das A, Emran TB, Mitra S, Islam F, Roy A, Karim MM, Das R, Park MN, Chandran D, Sharma R, Khandaker MU, Idris AM, Kim B. Mumu M, et al. Among authors: emran tb. Front Pharmacol. 2022 Aug 2;13:929442. doi: 10.3389/fphar.2022.929442. eCollection 2022. Front Pharmacol. 2022. PMID: 35983376 Free PMC article. Review.
Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review.
Karthic A, Roy A, Lakkakula J, Alghamdi S, Shakoori A, Babalghith AO, Emran TB, Sharma R, Lima CMG, Kim B, Park MN, Safi SZ, de Almeida RS, Coutinho HDM. Karthic A, et al. Among authors: emran tb. Front Cell Dev Biol. 2022 Sep 8;10:984311. doi: 10.3389/fcell.2022.984311. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158215 Free PMC article. Review.
Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach.
Akash S, Kumer A, Rahman MM, Emran TB, Sharma R, Singla RK, Alhumaydhi FA, Khandaker MU, Park MN, Idris AM, Wilairatana P, Kim B. Akash S, et al. Among authors: emran tb. Front Cell Infect Microbiol. 2022 Sep 27;12:952297. doi: 10.3389/fcimb.2022.952297. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36237438 Free PMC article.
A spotlight on alkaloid nanoformulations for the treatment of lung cancer.
S M S, Naveen NR, Rao GK, Gopan G, Chopra H, Park MN, Alshahrani MM, Jose J, Emran TB, Kim B. S M S, et al. Among authors: emran tb. Front Oncol. 2022 Oct 18;12:994155. doi: 10.3389/fonc.2022.994155. eCollection 2022. Front Oncol. 2022. PMID: 36330493 Free PMC article. Review.
400 results